title: Voice outcome following thyroplasty in patients with cancer-related vocal fold paralysis.
abstract: Medialization laryngoplasty restores voice in patients with unilateral laryngeal paralysis. Of question was whether patients with vocal fold paralysis resulting from cancer or its treatment had as good a post-operative voice result as patients with vocal fold paralysis of benign etiology. The purpose of the present study was to compare post-operative perceptual, acoustic, aerodynamic, and quality of life data in these two patient groups. Twenty-eight patients with vocal fold paralysis secondary to malignancy or its treatment were age and gender-matched with patients with paralysis resulting from benign origin. Pre- and post-operative perceptual judgments of pitch, loudness and quality were rated independently by two speech-language pathologists. A digital audiotape of the patient's voice was analyzed using Soundscope software. Fundamental frequency, conversational intensity and perturbation were evaluated. Glottal flow rates in propositional speech, phonation times and extent of pitch and loudness ranges were also measured. Three quality of life surveys, the Short Form-36 general health survey, the Voice Handicap Index, and the Voice Outcomes Study were administered. Results of voice testing indicated that perceptual, acoustic and aerodynamic data were significantly improved 3 months after thyroplasty in all patients regardless of whether they had a history of cancer. Quality of life data, however, distinguished the two groups. In particular, the general health measure found a significant difference in physical functioning and overall vitality, although satisfaction with improved voice was equally appreciated in both patient groups. Of clinical significance is that though general health may differ, patients with cancer-related laryngeal paralysis can expect to have as good a voice outcome following thyroplasty as patients with paralysis of benign etiology.
authors.affiliation: Department of Otolaryngology, Vanderbilt University Medical Center, Nashville, TN, USA. cheryl.billante@mcmail.vanderbilt.edu
authors.forename: C R
authors.initials: CR
authors.lastname: Billante
authors.forename: B
authors.initials: B
authors.lastname: Spector
authors.forename: M
authors.initials: M
authors.lastname: Hudson
authors.forename: K
authors.initials: K
authors.lastname: Burkard
authors.forename: J L
authors.initials: JL
authors.lastname: Netterville
mesh_terms: D000328:Adult; D000368:Aged; D004129:Dimethylpolysiloxanes; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000601:surgery*; D008297:Male; D008481:Mediastinoscopy; D008875:Middle Aged; D011183:Postoperative Complications / Q000175:diagnosis* / Q000209:etiology / Q000601:surgery*; D019736:Prostheses and Implants; D011788:Quality of Life; D012828:Silicones; D013018:Sound Spectrography; D013065:Speech Intelligibility; D013964:Thyroid Neoplasms / Q000601:surgery*; D016896:Treatment Outcome; D014826:Vocal Cord Paralysis / Q000209:etiology / Q000601:surgery*; D014833:Voice Quality
chemical_list: D004129:Dimethylpolysiloxanes; D012828:Silicones; C013830:baysilon